Multiple routes of protein transport from endosomes to the trans Golgi network  by Pfeffer, Suzanne R.
FEBS Letters 583 (2009) 3811–3816journal homepage: www.FEBSLetters .orgReview
Multiple routes of protein transport from endosomes to the trans Golgi network
Suzanne R. Pfeffer *
Department of Biochemistry, 279 Campus Drive B400, Stanford University School of Medicine, Stanford, CA 94305-5307, USA
a r t i c l e i n f o a b s t r a c tArticle history:
Received 28 August 2009
Revised 27 October 2009
Accepted 27 October 2009
Available online 29 October 2009
Edited by Antonella De Matteis
Keywords:
Endosome
Golgi
Rab GTPase
Mannose 6-phosphate receptor
Shiga and cholera toxin0014-5793/$36.00  2009 Federation of European Bio
doi:10.1016/j.febslet.2009.10.075
Abbreviations: MPR, mannose 6-phosphate recept
* Fax: +1 650 723 6783.
E-mail address: pfeffer@stanford.eduProteins use multiple routes for transport from endosomes to the Golgi complex. Shiga and cholera
toxins and TGN38/46 are routed from early and recycling endosomes, while mannose 6-phosphate
receptors are routed from late endosomes. The identiﬁcation of distinct molecular requirements
for each of these pathways makes it clear that mammalian cells have evolved more complex target-
ing mechanisms and routes than previously anticipated.
 2009 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Retrograde transport of proteins from endosomes to the trans
Golgi network (TGN) is a specialized pathway not taken by most
cell surface glycoproteins. Duncan and Kornfeld [1] used modiﬁca-
tion of galactose-terminating oligosaccharide chains to show that
most cell surface glycoproteins fail to reach TGN-localized sialyl-
transferase, but mannose 6-phosphate receptors (MPRs) are efﬁ-
ciently sialylated. In some cell types, transferrin receptors are
also resialylated [2]. Thus, the major cargoes studied in endosome
to Golgi transport are the MPRs, but additional cargoes include a
protein named TGN46 (same as TGN38), which is a TGN-localized
protein of unknown function that cycles between endosomes and
the TGN, the protein processing enzyme furin, and toxins that
are transported in a retrograde direction from endosomes through
the Golgi and back to the ER [3,4].
Using light microscopy, Mallet and Maxﬁeld [5] showed that
chimeric forms of furin and TGN38 use different routes to get to
the TGN. A Tac-TGN38 hybrid was transported from early endo-
somes via recycling endosomes to the TGN, while a Tac-furin con-
struct moved to the TGN via late endosomes. Tac-furin transport
was sensitive to nocodazole and wortmannin while Tac-TGN38
was only slowly blocked by wortmannin. Thus, the existence of
distinct routes to the TGN for those proteins that traverse thischemical Societies. Published by E
or; TGN, trans Golgi networkpathway was established over 10 years ago. Despite some confu-
sion in the literature, as described below, numerous lines of exper-
imentation and molecular distinctions show that MPRs are also
transported to the TGN via late endosomes.
Mallard et al. [6] showed early on that slowing Shiga toxin retro-
grade transport by low temperature resulted in signiﬁcant ultra-
structural co-localization of the toxin with transferrin receptor-
containing tubules that include recycling endosomes. That recycling
endosomes are important intermediates comes from the require-
ment for the recycling endosome-speciﬁc, Rab11 GTPase [7], EHD3
protein [8], as well as the proposed roles for Rabs21 and 22 [9].
Moreover, overexpression of the putative GAP protein, TBC1D14,
leads to the accumulation of this toxin in recycling endosomes [9].
This phenotype was obtained whether or not TBC1D14 carried a
mutation that should block its potential GAP activity. Its inhibition
of Shiga toxin transport is therefore likely due to titration of a limit-
ing binding partner of exogenous TBC1D14 – perhaps Rab11.
2. Mannose 6-phosphate receptor transport
MPRs carry newly made lysosomal enzymes from the Golgi to
early endosomes, and then return to the TGN to retrieve additional
cargo [10]. Live cell video microscopy has shown that MPRs depart
the Golgi in clathrin and GGA-coated, vesicular/tubular structures
[11,12] that contain Rab31 protein and are delivered to early endo-
somes [13,14].
Because depletion of a number of proteins leads to the
accumulation of MPRs in early endosomes (for example, AP1 [15]lsevier B.V. All rights reserved.
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transported from that compartment directly to the Golgi complex.
However, MPRs cannot release their bound ligands upon arrival in
early endosomes; they require a lower pH than typical endocytic
receptors for efﬁcient ligand release [18], and must pass through
a compartment of pH 6 5.5 prior to release bound ligands. In
normal cells, the majority of MPRs reside in more acidic late
endosomes at steady state [19]. The ﬁnding that the late endo-
somal Rab9 GTPase is required for MPR recycling [20–22] supports
a model in which MPRs travel from early endosomes to late endo-
somes before arrival at the TGN. More recent work demonstrating
the requirement for the late endosomal Rab7 GTPase in retromer
recruitment to membranes [23,24] (see below) conﬁrms the
importance of the late endosome compartment for MPR retrograde
transport. Live cell video microscopy has also detected the direct
transfer of vesicles from Rab9-positive, late endosomes to dis-
tinctly labeled Golgi complexes, marked with GFP-galactosyltrans-
ferase [25]. Thus, it is likely that MPRs travel from early endosomes
to late endosomes en route to the Golgi complex.
Could MPRs be transported from early endosomes directly to
the TGN? If MPRs could traverse directly from early endosomes
to the Golgi, loss of the late endosomal Rab7 or Rab9 should be
inconsequential for MPR recycling since late endosomes could be
bypassed. Yet we have shown that loss of Rab9 strongly destabi-
lizes MPRs and triggers their mis-sorting to lysosomes [22,26]. Loss
of Rab7 interferes with MPR transport [23,24]. As discussed below,
the same is true in cells lacking the Rab9 effectors, TIP47 [22,27],
GCC185 [28], and RhoBTB3 [29] – MPRs cannot bypass a require-
ment for these Rab9 effectors by rerouting through early endo-
somes to the Golgi. Thus, early microscopy and more recent
molecular distinctions between early and recycling endosome to
Golgi transport and late endosome to Golgi transport (discussed
below) conﬁrm the existence of distinct pathways for receptor
transport (Fig. 1).
Retromer is clearly important for MPR recycling, as are Rab7
and Rab9, two late endosome speciﬁc Rab GTPases. Why then doFig. 1. Sorting of retrograde cargoes in endosomes. MPRs (red bars) and toxins
(green spheres) are present in early endosomes and are sorted in that compartment
prior to delivery to the Golgi complex. The toxins are directed towards Rab11-
containing recycling endosomes prior to arrival at the Golgi. Rabs 21 and 22 may
also play a role at this location [9]. MPRs are sorted towards Rab7 and Rab9-
compartments. Both cargoes use Retromer as they leave early endosomes. Because
toxins use recycling endosomes, and retromer depletion accumulates toxins in early
endosomes, the presumed step is at early endosome exit. Similarly, for MPRs, exit
from early endosomes is the presumed site of retromer function. Distinct Golgins
and SNARE complexes at the TGN participate in vesicle receipt. This includes the
GARP complex [64]. See text for additional details.MPRs accumulate in early endosomes when retromer is depleted,
and show a more rapid rate of degradation, if retromer functions
in exit from early endosomes (Fig. 1)? One possibility is that retr-
omer-deﬁcient early endosomes are direct targets for lysosomal fu-
sion rather than the normal progression via late endosomes for
degradation. Indeed, perhaps the role of Rab7 interaction with retr-
omer is to guide early to late endosome trafﬁcking. It will be
important to learn whether other protein partners are concomi-
tantly lost in cells depleted of retromer subunits to better under-
stand this phenotype. For the time being, Fig. 1 presents a
working model that is consistent with existing data.3. Molecular requirements distinguish multiple retrograde
transport routes
An excellent review highlighting a long and growing list of dis-
tinct molecular requirements for toxins, MPRs and other retro-
grade cargoes was recently published [3]. Of particular note is
the distinct requirement for Syntaxin 10 (STX10) for MPR recycling
to the TGN [26] where it functions as part of a STX16, Vti1A and
VAMP3-containing SNARE complex [26,30,31]. Shiga toxin, cholera
toxin and ricin utilize a different SNARE complex containing STX6,
STX16, Vti1a and the v-SNAREs, VAMP3 or VAMP4, as well as the
Rab6A GTPase [32] but not Rab9 GTPase [33,34]. While TGN46
and cholera toxin require STX6, MPR recycling does not
[26,30,31]. The putative tethering proteins, Golgin-97 [35] and Gol-
gin-245 [36] are both important for Shiga toxin retrograde trans-
port. In contrast, MPRs (but not cholera toxin) use GCC185 [28],
and TGN38 (but not Shiga toxin) uses the GCC88 protein [37].
The distinction between STX10/Rab9 and GCC185-independent,
early/recycling endosome to Golgi transport of TGN38/46 and Shi-
ga and cholera toxin, versus STX10/Rab9 and GCC185-dependent
transport of MPRs (Fig. 1) provides molecular proof of the distinc-
tion between these two transport routes. Why cells have evolved
such complex machineries is not entirely clear.
It should be noted that STX10 blocks MPR export from early
endosomes despite the fact that STX10 is primarily a Golgi local-
ized t-SNARE [23]. From this, we have concluded that STX10 may
function at both early to late endosome transport as well as late
endosome to TGN transport [23]. Nevertheless, it was not needed
for cholera toxin transport, conﬁrming a molecular distinction be-
tween toxin transport and MPR transport and their distinct trans-
port routes between endosomes and the Golgi complex.
Despite many differences, the pathways share a number of
components including retromer components and cytoplasmic dy-
nein. This suggests either a common, early step prior to sorting,
or the use of common components after an initial sorting process.
Future work will be needed to address this in greater detail. Here, I
will focus on the components that facilitate MPR transport from
late endosomes to the TGN.4. Rab9 effectors in MPR retrograde transport
Rab9-dependent transport from late endosomes to the Golgi re-
quires the Rab9 effectors, p40 [38] and TIP47 [27], a protein that
recognizes the cytoplasmic domains of the two types of MPRs
and packages them into nascent transport vesicles [39]. MPR recy-
cling also utilizes a TGN-localized, coiled-coil protein named
GCC185 that is also a Rab9 effector [28,40]. GCC185 is a putative
transport vesicle tether that associates with the TGN by interaction
of its C-terminus with both Rab6 and Arl1 GTPases. GCC185 has
numerous, additional Rab binding sites across its entire length
[41]. Also at the TGN is the RhoBTB3 ATPase that has been pro-
posed to participate in the uncoating of transport vesicles upon
their arrival at the TGN [29].
Fig. 2. TIP47 binds MPRs in living cells and stabilizes them. (A) F236 was shown to
be important for MPR binding because mutation of this residue to a cysteine
increased TIP47 binding ﬁvefold. The structure shown is from [47] (PDB 1SZI). (B)
TIP47 F236C with enhanced afﬁnity for MPR cytoplasmic domains increases the
amount of membrane-associated TIP47 protein in transfected cells. Shown are the
relative ratios of membrane and cytosol-associated TIP47 protein comparing wild-
type and mutant protein-expressing cells. (C) Cells expressing F236C TIP47 show a
higher steady state level of MPRs, presumably due to stabilization by direct binding.
(D) Expression of TIP47 F236C stabilizes MPRs as seen when the protein half life is
compared with cells in which TIP47 wild-type protein is expressed. Data were
presented in [48] and the ﬁgure was redrawn.
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We discovered TIP47 in a yeast two hybrid screen, looking for
proteins that bound to the cytoplasmic domains of both the cat-
ion-independent and cation-dependent MPRs [27]. Puriﬁed, re-
combinant TIP47 binds both MPR cytoplasmic domains directly,
and although the majority of TIP47 is cytosolic, a fraction co-local-
izes in cells with perinuclear MPRs and co-fractionates with endo-
somal markers upon sucrose gradient ﬂotation. Depletion of TIP47
using antisense oligonucleotides [27] or siRNA [22] strongly desta-
bilizes MPRs in living cells, and antibody-depletion of TIP47 from
cytosol leads to a complete loss of cytosol activity in terms of its
ability to support in vitro transport of MPRs from endosomes to
the TGN [27]. The association of cytosolic TIP47 with endosome-
enriched membranes can be blocked by anti-MPR cytoplasmic do-
main antibodies, and binding requires speciﬁc residues in each of
the MPRs: a FW sequence in the CD-MPR and a proline-rich se-
quence in the CI-MPR [42]. Binding is somewhat stronger to the
CI-MPR than to the CD-MPR (1 lM versus 3 lM [43]) and no bind-
ing is seen with TGN38 or LDL-receptors. Importantly, TIP47
expression actually stimulates MPR transport to the TGN [39,44].
These data strongly support a model in which TIP47 acts as a cargo
selection device for MPR retrograde transport.
TIP47 also binds the late endosomal Rab9 GTPase [39]. Impor-
tantly, Rab9 binding increases the afﬁnity with which TIP47 binds
CI-MPR cytoplasmic domains: the Kd improves from 0.9 lM to
0.3 lM. Moreover, the interaction of TIP47 with Rab9 is needed
for its ability to stimulate the transport of MPRs from late endo-
somes to the TGN [39,45], and expression of a mutant TIP47 pro-
tein that cannot bind Rab9 changes the morphology of late
endosomes [25]. These data indicate that TIP47 is recruited onto
late endosomes by Rab9 GTPase, which participates in cargo collec-
tion by TIP47 protein.
We used mis-incorporator tRNAs to generate a large number of
TIP47 mutant proteins and combined this with afﬁnity chromatog-
raphy to identify two TIP47 variants with increased (F236C) or de-
creased (I214C) afﬁnity for MPR cytoplasmic domains [46].
Localization of these amino acid residues on the three-dimensional
structure of TIP47 [47] revealed a binding pocket that can accom-
modate the MPR cytoplasmic domains (Fig. 2A). A TIP47 F236C
mutant protein binds MPR cytoplasmic domains with a Kd of
0.2 lM, which may reﬂect the high afﬁnity state observed for
wild-type MPR binding to TIP47 in the presence of Rab9 GTPase.
The ability of these mutant proteins to bind MPRs correlates with
their relative membrane/cytosol distributions in transfected cells
([48]; Fig. 2B). Also, TIP47 F236C stabilizes MPRs from degradation
in transfected cells (Fig. 2C and D) under conditions in which Rab9
turnover is unchanged [48]. These ﬁndings demonstrate that TIP47
interacts with MPRs in living cells and inﬂuences their fate.
The importance of TIP47 in Rab9 function is further highlighted
by our surprising ﬁnding that depletion of TIP47 destabilized Rab9
protein [22]. Importantly, the total level of Rab9 does not change,
but its rates of degradation and new synthesis do. Intracellular
interaction of TIP47 with Rab9’s hypervariable domain was shown
deﬁnitively by relocalization of a chimeric Rab5/Rab9 protein
[49]. The Rab5/Rab9 chimera binds both Rab5 effectors and less
abundant Rab9 effectors. Simply introducing more TIP47 into cells
moved the Rab5/9 protein fromearly endosomes to late endosomes.
Thus, TIP47 binds both Rab9 andMPRs in live cells, and is important
for the stability of both of these proteins, via precise residues that
comprise the distinct Rab9 and MPR binding sites on TIP47.
Most TIP47 protein is cytosolic. In some cell types and under
several physiological conditions, TIP47 is also present on lipid
droplets, and its role there is also currently an area of active inves-
tigation (see [50] for review). Recently, Bulankina et al. [51] chal-lenged some of our previous work on TIP47 as a Rab9 effector
and MPR modulator. There are trivial reasons why these workers
may have obtained different results. The C-terminus of Rab9 is
essential for TIP47 binding [49] and was very likely not present
in their Rab preparations because wild-type Rab9 loses its 23 C-ter-
minal most residues upon expression in bacteria [20,52]. As men-
tioned above, most TIP47 is cytosolic so to see it on late
endosomes, one must permeabilize cells under conditions that per-
mit slow release of cytosol (liquid nitrogen freeze thaw or digito-
nin before ﬁxation) (see [27]). This may explain Bulankina et al.’s
failure to detect TIP47 on the structures that we readily detect:
they used Saponin permeabilization and very little TIP47 staining
was seen in their images.
6. Rab9 and TIP47 are key for the production of several viruses
Rab9 and TIP47 are important for the production of infectious
HIV particles [53–55]; indeed, Ebola virus, Marburg virus, and
measles virus all require Rab9 GTPase function and certain Rab9
effectors [56] for their biogenesis. Vaccinia virus p37 protein also
interacts with TIP47 during the process of intracellular mature
virus production [57]. Finally, cellular intoxication by Pseudomonas
exotoxin appears to use a Rab9 dependent pathway, unlike cholera
and Shiga toxins [34].
7. Rab6 anchors the GCC185 tethering protein for MPR recycling
Rab6 is an important player in the retrograde transport of all
cargoes. For MPRs, it plays an unexpected role in the anchoring
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immediately upstream of a C-terminal, Arl binding GRIP domain in
GCC185 (Fig. 3). Isothermal titration calorimetry revealed that
Rab6 binds to this site with an afﬁnity of 2.3 lM. We identiﬁed a
mutant protein (I1588A/L1595A) that was signiﬁcantly diminished
in its ability to bind Rab6. These residues lie at the interface be-
tween Rab6 and GCC185. In the context of full length GCC185 pro-
tein, mutation of these residues generates a protein that is not
Golgi-localized, demonstrating their importance for Golgi localiza-
tion [58]. Consistent with this ﬁnding, siRNA depletion of Rab6 de-
creased the ability of the GCC185 C-terminus to bind to the Golgi.
To our surprise, however, Arl1 depletion also blocked Golgi associ-
ation of the GCC185 C-terminus. One possible explanation would
be that both Arl1 and Rab6 contributed to localization. To test this,
we measured directly the afﬁnity of GCC185 for Arl1. The afﬁnity is
7 lM but improves twofold such that at certain concentrations, the
concomitant presence of Rab6 and Arl1 led to a sevenfold increaseFig. 3. A model for anchoring of the C-terminus of the GCC185 Golgin (green) with
the trans Golgi network (marbled platform). Shown are Rab6 GTPase (blue) with its
C-terminal, unstructured hypervariable domain (red), anchored to the membrane
by two, C-terminal, geranylgeranyl moieties, and Arl1 GTPase (gray) anchored to
the membrane by a myristoylated, hydrophobic N-terminus (red). The structure of
the GCC185 Rab binding domain (RBD) bound to Rab6 GTPase (PDB 1D 3BBP) was
from [58]; the structure of the Arl1 GTPase bound to the GRIP domain (PDB 1D
1UPT) was modeled from [65]. Although GCC185 binds as many as 14 other GTPases
across its length [41], only the Rab6:GCC185 interface shown here is essential for
GCC185’s TGN association.
Fig. 4. Two hybrid detection of the interaction of GCC185 C-terminal 110 residues with
[41] with Rab6A, 6B, and Rab1A in a Gal4BD fusion (pGBT9) and GCC185 C110 in a Gal4A
of the same yeast strains to reveal interaction is shown at right.in GCC185 binding [58]. Thus, careful biochemistry revealed com-
plex modes of interaction that could not have been detected by
immunoﬂuorescence assays. It therefore appears that Rab6 en-
hances the ability of Arl1 to bind the GCC185 GRIP domain to local-
ize this protein at the TGN [58].
Recently, Houghton et al. [59] questioned our model. We wel-
come any alternative model that can also explain all the data in
the literature and most importantly, can be tested experimentally;
unfortunately, Houghton et al. did not provide one. Our siRNA
experiments absolutely required very efﬁcient depletion of Arl1
and Rab6. Houghton et al. [59] report only 80% depletion by the
appropriate immunoblot assay, which would not have been ade-
quate to see an effect. Houghton et al. [50] were concerned that
most cellular GCC185 does not co-localize with Rab6. We know,
for example, that Rab6 plays an important role on post-Golgi trans-
port vesicles [60] but most does not localize there. Lack of majority
co-localization does not in any way rule out essential roles for pro-
tein-protein interactions. Houghton et al. noted that it is easier to
displace Golgin 245 and Golgin 97 in Arl1 depletions. We agree
completely and this is easily explained – those proteins bind Arl1
more tightly (2 lM), and do not appear to also require Rab6.
Houghton et al. also found that the C-terminal 200 residues of
GCC185 are more efﬁciently localized to the Golgi than the C-ter-
minal most, 82 residues. That ﬁts our data and our model but it
should also be noted that the C-terminal, 82 residue fragment in-
cludes part of the Rab6 binding site and also part of the Rab9 bind-
ing site. Finally, Houghton et al. fail to detect Rab6 binding to the C-
terminal 110 residues by yeast two hybrid. Negative yeast two hy-
brid should never be used as a ﬁnal assessment of ‘‘in vivo” pro-
tein:protein interactions since there are many reasons that
negative results can be obtained. Indeed, we tested this precise
interaction and in this lab, Rab6A and 6B binding to the 110 C-ter-
minal residues of GCC185 can be detected by yeast two hybrid
(Fig. 4). In summary, careful biochemistry combined with quantita-
tive light microscopy support a role for Rab6 and Arl1 GTPases in
GCC185 localization. Arl1 is already known to be important for
the localization of Golgin-97, and Golgin-245. Other Rab6 effectors
play critical roles for Shiga toxin transport [3] and include TMF/
ARA160 [61]. The full list of Rab6 effectors that participate in ret-
rograde transport pathways will be important to obtain.
8. The Rab9 effector, RhoBTB3, is needed for MPR retrieval
Rho BTB3 was discovered in a yeast two hybrid screen as a pro-
tein that binds active Rab9 GTPase and is required for MPR recy-
cling to the Golgi complex [29]. The protein has an N-terminal,
Rho GTPase-related domain and a C-terminal BTB domain that is
likely a dimerization module (Fig. 5). The Rab9 binding site lies just
downstream of the BTB domain.Rab6A and Rab6B, but not Rab 1A. This experiment was carried out as described in
D fusion (pACT2). Non-selective growth condition is shown at left; selective growth
Fig. 5. Domain analysis of RhoBTB3. RhoBTB3 has an N-terminal Rho GTPase-
related ATPase domain and a C-terminal Rab9 binding site. A BTB domain that may
be responsible for dimerization is also shown. Binding of Rab9 activates the
RhoBTB3 ATPase by release of autoinhibition of this enzyme. See [29] for more
details.
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nucleotide binding pocket of RhoBTB3 were used to demonstrate
the importance of both of these domains of RhoBTB3 in siRNA
depletion and plasmid rescue experiments [29]. To our surprise,
the Rho GTPase domain encodes an ATPase with kinetic properties
of a molecular chaperone. Moreover, we detected interaction of
RhoBTB3 with TIP47 on membranes. One possibility that will re-
quire future work is that the Golgi-localized RhoBTB3 uncoats
incoming transport vesicles carrying MPRs. Satisfyingly, Rab9
binding relieves autoinhibition of RhoBTB3’s ATPase activity [29].
Rab9 GTPase is present on the surface of inbound transport vesicles
[25], and would be in the right place at the right time to turn on a
vesicle-uncoating enzyme. The full range of RhoBTB3 substrates
will be important to determine in the future.
9. Endosome maturation in retrograde sorting
The importance of organelle maturation as part of membrane
trafﬁc has been underscored by the recent demonstration of late
endosome maturation from early endosomes by Rab conversion
[62]. In this case, loss of the early endosomal Rab5 is coordinated
with acquisition of the late endosomal Rab7; in this manner a gi-
ven membrane changes its molecular functionality. Segregation
of proteins into distinct domains on a given membrane may be suf-
ﬁcient in some cases to alter their routing. Speciﬁcally, if Rab11/
Rab21/Rab22 and their effectors encounter recycling cargoes in
early endosomes or in recycling endosomes, the fate of those car-
goes may be the same. The only difference might be whether a mo-
tor protein has facilitated the dispersal of a Rab11 domain from a
Rab5 domain on the early endosome. This subtlety may have
caused some confusion for those analyzing endosome to Golgi
transport – the speciﬁc molecular requirements provide a more
precise description of pathways taken rather than broader, endo-
some names. Within the Golgi, Rab conversion also takes place
[63] and may account for maturation of cisternae in yeast Golgi
and for maturation of mammalian cell Golgi carrying larger than
normal cargo proteins.
Because Rab GTPases deﬁne function-specifying membrane
microdomains, their participation or lack thereof is essential for
our understanding of trafﬁcking routes. As mentioned earlier, the
toxins do not require Rab9 but late endosome-derived cargoes do.
10. Summary and future perspectives
All of the above data suggest that the earliest sorting events
take place in early endosomes to segregate toxins from other, lateendosome-bound, retrograde cargoes. How this sorting takes place
and why it is important for cells are fundamental questions of
broad importance. Why do cargoes use multiple tethering factors
for successful delivery to the TGN? Perhaps this redundancy en-
sures successful transport. Yet individual depletions show strong
phenotypes, suggesting that the functions of TGN tethers are not
entirely overlapping. Functional tethering studies will soon reveal
the mechanisms by which multiple transport carrier types are able
to identify their TGN targets and fuse with that compartment. Elu-
cidation of the full repertoire of Rab effectors mediating retrogade
transport should provide an enormous amount of molecular detail
and clues to the mechanisms of protein sorting and transport from
endosomes to the Golgi of mammalian cells.
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